Earnings call transcript: Lemonsoft Q1 2026 shows SaaS growth amid sales dip

Lemonsoft’s Q1 2026 results were mixed but skewed positive: SaaS revenue rose 7%, operating margin improved 270 bps to 25.8%, and recurring revenue reached 88.5% of sales, while net sales fell 1.1% on weaker consulting and transaction revenue. The Jakamo acquisition is expected to boost results further from Q2 onward, and management said operating margins should keep improving through 2026. The stock was unchanged despite the earnings update, reflecting balanced near-term positives and execution risks.

Analysis

The real signal here is not just margin expansion; it’s the combination of recurring-revenue mix shift and integration leverage starting to show up before the acquisition is fully embedded. That usually creates a lagged re-rate: the market first discounts the headline sales softness, then later pays for higher quality of revenue once the base becomes more subscription-like and consultative drag fades. The incremental AI/workflow messaging matters less as a near-term monetization lever than as a retention tool that can slow churn and raise switching costs in the SME ERP stack.

Second-order winner: the acquirer’s ecosystem partners and smaller vertical software peers that lack a supply-chain collaboration layer. If the new platform actually reduces point-to-point integration pain, the company can become a distribution node rather than just an ERP vendor, which is more valuable because it widens attach rates across modules and raises the payoff from each new customer logo. The risk is that implementation complexity and support load can delay the intended operating leverage for 1-2 quarters, especially if management keeps adding sales/customer-success headcount faster than monetization scales.

The setup looks most compelling over the next 2-3 quarters, not days. Near-term upside is driven by the first clean read on post-acquisition run-rate contribution and whether gross margin holds despite heavier integration spend; downside comes if consulting/transaction decay accelerates faster than SaaS growth can offset it. The market may be underestimating how much of the valuation reset is already baked in if the company can simply maintain mid-single-digit SaaS growth while preserving high-20s operating margins; that can support a meaningful multiple expansion from a depressed base.

Contrarian view: the consensus is treating this as a classic ‘quality shift’ story, but the better read may be ‘unfinished transition’ with hidden execution risk. The stock can stay cheap longer if investors decide recurring mix is being flattered by price increases and acquisition accounting rather than durable underlying demand. The clearest invalidation is a couple of quarters where operating margin stalls while top-line organic growth remains negative; that would tell you the model is not yet self-funding its transformation.

Key Decisions for Investors

• Long LEMON over 3-6 months only on evidence of post-Jakamo acceleration; use a starter position now and add if next quarter shows SaaS growth inflecting without margin giveback. Risk/reward: attractive if the market re-rates recurring mix, but size modestly because execution risk is still the main variable.
• Pair trade: long LEMON / short a legacy ERP or vertical software peer with lower recurring mix and higher services exposure over the next 1-2 quarters. Thesis is that the market should reward revenue quality and integration optionality while penalizing companies with more cyclical revenue.
• If options are available, buy 3-6 month calls financed by selling downside puts only if you’re willing to own the stock near the 52-week lows. This expresses a view that the next catalyst is a cleaner ARR and margin update, while limiting capital at risk.
• Avoid chasing on the current headline strength; wait for confirmation that gross margin stays above the low-80s sequential trough and that M&A contribution is fully visible in the next report. The best entry is usually after the first post-deal print, not before.